Pfizer Japan, Maker Of Champix, To Ban Smoking At Tokyo HQ
This article was originally published in PharmAsia News
Executive Summary
Pfizer Japan, which markets Champix (varenicline) to treat nicotine addiction, announced a smoking ban in its Tokyo premises effective June 1